ReviewBiological psychiatry2026
Depression as a Disease of White Matter Network Disruption: Learning From Multiple Sclerosis.
Review in Biological psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Depression is a common and debilitating psychiatric disorder that is associated with substantial morbidity and mortality. For nearly 40 years, scientists have attempted to localize depression in the brain with neuroimaging. Despite concerted research, many meta-analyses of neuroimaging research in depression have not identified a single brain region that, when lesioned, causes depression. However, recent work using coordinate and lesion network mapping has identified a distributed network from functional magnetic resonance imaging that is relevant for depression. In this review, we propose that multiple sclerosis (MS) is a powerful model to study the relationship between perturbations to white matter brain networks and depression. We highlight recent successes in using lesion network mapping to find associations between depression and MS lesion location and burden in retrospective samples. Next, we describe why prospective, longitudinal studies that track the onset of white matter lesions in MS with the emergence and resolution of depression may provide a way to understand both the pathophysiology of depression in MS and network mechanisms of depression more broadly.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.